Antacid
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
2695 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 318 | 7 | 1 | 14 | 15 | 351 |
| Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | 42 | 40 | 92 | 88 | 62 | 308 |
| Infections | D007239 | EFO_0000544 | — | 18 | 21 | 27 | 118 | 58 | 233 |
| Hemorrhage | D006470 | MP_0001914 | R58 | 7 | 18 | 49 | 41 | 49 | 158 |
| Ulcer | D014456 | MPATH_579 | — | 7 | 18 | 57 | 33 | 20 | 128 |
| Helicobacter infections | D016481 | EFO_1000961 | — | 6 | 9 | 21 | 55 | 30 | 115 |
| Peptic esophagitis | D004942 | EFO_1001095 | — | 12 | 14 | 47 | 26 | 20 | 114 |
| Esophagitis | D004941 | HP_0100633 | K20 | 8 | 19 | 34 | 19 | 8 | 85 |
| Communicable diseases | D003141 | — | — | 8 | 11 | 11 | 31 | 20 | 78 |
| Peptic ulcer | D010437 | — | K27 | 5 | 4 | 18 | 32 | 12 | 71 |
Show 297 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 6 | 14 | 4 | — | 2 | 23 |
| Lymphoma | D008223 | — | C85.9 | 7 | 5 | 2 | — | 4 | 18 |
| Leukemia | D007938 | — | C95 | 5 | 6 | 1 | — | 2 | 12 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | 7 | 4 | — | — | 10 |
| Head and neck neoplasms | D006258 | — | — | — | 5 | 3 | — | 2 | 9 |
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | — | 4 | 2 | — | 3 | 8 |
| Dermatitis | D003872 | — | L30.9 | 4 | 1 | 1 | — | 1 | 7 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 1 | 6 | 1 | — | 1 | 7 |
| Heart failure | D006333 | EFO_0003144 | I50 | 1 | 2 | 2 | — | 1 | 6 |
| Atopic dermatitis | D003876 | EFO_0000274 | L20 | 4 | — | 1 | — | 1 | 6 |
Show 111 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Malaria | D008288 | EFO_0001068 | B54 | 23 | 4 | — | — | — | 23 |
| Falciparum malaria | D016778 | EFO_0007444 | B50 | 10 | 2 | — | — | — | 10 |
| Hookworm infections | D006725 | EFO_0007314 | B76 | 8 | 1 | — | — | — | 9 |
| Ancylostomiasis | D000724 | EFO_0007145 | B76.0 | 8 | 1 | — | — | — | 9 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 3 | 2 | — | — | 3 | 8 |
| Carcinoma | D002277 | — | C80.0 | 1 | 5 | — | — | 1 | 7 |
| Fatty liver | D005234 | EFO_0003934 | — | 2 | 4 | — | — | 1 | 6 |
| Coronavirus infections | D018352 | EFO_0007224 | B34.2 | 1 | 5 | — | — | — | 6 |
| Melanoma | D008545 | — | — | 3 | 3 | — | — | — | 5 |
| Replacement arthroplasty knee | D019645 | — | — | — | 1 | — | — | 4 | 5 |
Show 142 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetics | D010599 | — | — | 16 | — | — | — | 1 | 17 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | 8 | — | — | — | — | 8 |
| Dengue | D003715 | — | A90 | 6 | — | — | — | — | 6 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 4 | — | — | — | 1 | 5 |
| Therapeutic equivalency | D013810 | — | — | 5 | — | — | — | — | 5 |
| Hepatitis c | D006526 | — | B19.2 | 5 | — | — | — | — | 5 |
| Non-small-cell lung carcinoma | D002289 | — | — | 4 | — | — | — | 1 | 5 |
| Biological availability | D001682 | — | — | 3 | — | — | — | 1 | 4 |
| Papillomavirus infections | D030361 | — | — | 2 | — | — | — | 1 | 3 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 3 | — | — | — | — | 3 |
Show 81 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | — | 11 | 11 |
| Necrosis | D009336 | — | — | — | — | — | — | 5 | 5 |
| Intracranial aneurysm | D002532 | EFO_0003870 | I67.1 | — | — | — | — | 5 | 5 |
| Osteonecrosis | D010020 | EFO_0004259 | M87 | — | — | — | — | 4 | 4 |
| Aneurysm | D000783 | — | I72.9 | — | — | — | — | 4 | 4 |
| Spinal stenosis | D013130 | EFO_0007490 | M48.0 | — | — | — | — | 2 | 2 |
| Thyroid neoplasms | D013964 | EFO_0003841 | — | — | — | — | — | 2 | 2 |
| Glucose metabolism disorders | D044882 | — | — | — | — | — | — | 2 | 2 |
| Chronic periodontitis | D055113 | EFO_0006343 | K05.3 | — | — | — | — | 2 | 2 |
| Fatigue | D005221 | — | R53.83 | — | — | — | — | 2 | 2 |
Show 141 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
827 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use